Viral infections in pediatric solid organ transplantation recipients and the impact of molecular diagnostic testing

Abstract

Viral infections remain a leading cause of morbidity and mortality in the solid organ transplantation population, particularly in pediatric patients. Whereas diagnostic testing has greatly improved, there is an urgent need for the development of novel therapies, including adoptive immunotherapy, to provide well tolerated and effective therapy.